Clinical Trials of Self-Replicating RNA-Based Cancer Vaccines

0
178
Scientists review the clinical experience with self-replicating RNA-based cancer vaccines, and recent safety data from a study combining a viral replicon particles encoding HER2 plus an anti-PD1 monoclonal antibody.
[Cancer Gene Therapy]
Full Article